The folate receptor beta (FRβ) is specifically overexpressed on M2-polarized TAMs in various epithelial malignancies, including ovarian cancer, making it a promising immunotherapeutic target for modulating the tumor microenvironment (39). This evidence concerns the gene FOLR2 and neoplasm.